Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Soumya G Chikermane"'
Autor:
James E. Harvey, Samir R. Kapadia, David J. Cohen, Ankur Kalra, William Irish, Candace Gunnarsson, Michael Ryan, Soumya G. Chikermane, Christin Thompson, Rishi Puri
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 13, Iss 17 (2024)
Background The treatment of severe aortic stenosis has evolved considerably since the introduction of transcatheter aortic valve replacement (TAVR), yet trends in complications for patients undergoing TAVR or surgical aortic valve replacement (SAVR)
Externí odkaz:
https://doaj.org/article/9acd5c883798498887d64bfa33b97ba2
Autor:
Mark J. Russo, MD, Sammy Elmariah, MD, MPH, Tsuyoshi Kaneko, MD, David V. Daniels, MD, Rajendra R. Makkar, MD, Soumya G. Chikermane, PhD, Christin Thompson, PhD, Jose Benuzillo, MS, Seth Clancy, MPH, Amber Pawlikowski, MSN, Skye Lawrence, BA, Jeff Luck, MBA, PhD
Publikováno v:
JACC: Advances, Vol 3, Iss 8, Pp 101116- (2024)
Background: Transcatheter aortic valve replacement (TAVR) is an important treatment option for patients with severe symptomatic aortic stenosis. It is important to identify predictors of excellent outcomes (good clinical outcomes, more time spent at
Externí odkaz:
https://doaj.org/article/11b7388757c54e28923bb6b6e70c73f4
Autor:
Mantasha Tabassum, Soumya G. Chikermane, Camille Johnson, Noor M. Abdulkareem, Elisabeth M. Wang, Michael L. Johnson, Meghana V. Trivedi
Publikováno v:
Cardio-Oncology, Vol 10, Iss 1, Pp 1-7 (2024)
Abstract Background Cardiovascular (CV) disease is a leading cause of death in breast cancer (BC) patients due to the increased age and treatments. While individual β-blockers have been investigated to manage CV complications, various β-blockers ha
Externí odkaz:
https://doaj.org/article/d68bdaebd5e34cefa3a68098abf8e26f
Autor:
Soumya G. Chikermane, Manvi Sharma, Susan M. Abughosh, Rajender R. Aparasu, Meghana V. Trivedi, Michael L. Johnson
Publikováno v:
Breast Cancer Research and Treatment. 195:421-430
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8ae97f06ed92aad3f865e4aa55de24fb
https://doi.org/10.1007/s10549-022-06706-0
https://doi.org/10.1007/s10549-022-06706-0
Autor:
Noor M Abdulkareem, Soumya G Chikermane, Suma Gopinathan, Michael L Johnson, Meghana V Trivedi
Publikováno v:
Cancer Research. 82:P2-11
Background: Breast cancer mortality has decreased along with advances in diagnosis and treatments. However, cardiovascular (CV) disease-related mortality is a growing concern in this population. Increased risk of CV diseases is primarily contributed
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::822618b1714cfa8485203f31e3c76bec
https://doi.org/10.1158/1538-7445.sabcs21-p2-11-09
https://doi.org/10.1158/1538-7445.sabcs21-p2-11-09
Publikováno v:
Multiple Sclerosis and Related Disorders. 60:103703
Since the introduction of oral disease-modifying agents (DMA) in 2010, the treatment options for multiple sclerosis (MS) have changed significantly. There is limited information regarding the factors associated with switching to oral DMA among preval
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1f88facd4a1b1c5874c1704b0cd30804
https://doi.org/10.1016/j.msard.2022.103703
https://doi.org/10.1016/j.msard.2022.103703